Shopping Cart 0
Cart Subtotal
USD 0

NovaBay Pharmaceuticals Inc (NBY) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

NovaBay Pharmaceuticals Inc (NovaBay), formerly NovaCal Pharmaceuticals Inc is a biopharmaceutical company that discovers and develops eyecare products. The company's products include skin and wound cleanser, daily lid and lash hygiene spray solutions, and cosetic procedures. Its daily lid and lash hygiene spray solution helps in removal of foreign materials such as microorganisms and debris on and around the lid and eyelid margins. NovaBay develops aganocide compound through research and development based on the human body's natural immune system and molecules involved in combating infections. The company's products find application in therapeutic areas such as ophthalmology, wound care, dermatology, and neutrophase. It partners with pharmaceutical and biotech companies. NovaBay is headquartered in Emeryville, California, the US.

NovaBay Pharmaceuticals Inc (NBY)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

NovaBay Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

NovaBay Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

NovaBay Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

NovaBay Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

NovaBay Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 10

NovaBay Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

NovaBay Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 13

Partnerships 13

ALPHAEON Enters into Agreement with NovaBay Pharma 13

NovaBay Pharma Enters into Distribution Agreement with Cardinal Health for Avenova 14

NovaBay Pharma Enters into Distribution Agreement with Biopharm for NeutroPhase 15

NovaBay Pharma and Principle Business Enterprises to Sign Distribution Agreement 16

NovaBay Pharma and Integrated Healing Technologies to Sign Distribution Agreement 17

Licensing Agreements 18

NovaBay Pharma Enters Into Licensing Agreement With China Pioneer Pharma For CelleRx And i-Lid Cleanser 18

Shin Poong Enters Into Licensing Agreement With NovaBay For NeutroPhase 19

Equity Offering 20

NovaBay Pharma Raises USD5.9 Million in Private Placement of Shares 20

NovaBay Pharma Files Registration Statement for Public Offering of Shares 22

NovaBay Pharma to Raise USD10.3 Million in Private Placement of Shares 23

NovaBay Pharma Raises USD0.9 Million in Private Placement of Shares upon Exercise of Warrants 24

NovaBay Pharma Raises USD7 Million in Private Placement of Shares upon Exercise of Warrants 25

NovaBay Pharma Raises USD6.9 Million in Private Placement of Shares upon Exercise of Warrants 26

NovaBay Pharma Raises USD4 Million in Second and Final Tranche of Private Placement of Units 27

NovaBay Pharma Raises USD7.8 Million in First Tranche of Private Placement of Units 28

NovaBay Pharma Raises USD2.8 Million in Private Placement of Shares 29

NovaBay Pharma Raises USD2.5 Million in Public Offering of Shares 30

NovaBay Pharma Raises USD6.9 Million in Private Placement of Shares and Warrants 32

NovaBay Pharma Raises USD4.7 Million in Private Placement of Units 33

NovaBay Pharma Raises USD6.7 Million in Public Offering of Units 34

NovaBay Pharma Completes Public Offering Of Shares For USD 7 Million 35

Acquisition 36

Ch-Gemstone Acquires 37.14% Stake in NovaBay Pharma for USD27.1 Million 36

NovaBay Pharmaceuticals Inc-Key Competitors 37

NovaBay Pharmaceuticals Inc-Key Employees 38

NovaBay Pharmaceuticals Inc-Locations And Subsidiaries 39

Head Office 39

Recent Developments 40

Financial Announcements 40

Aug 07, 2018: Novabay Pharmaceuticals announces second quarter 2018 financial results 40

May 10, 2018: NovaBay Pharmaceuticals Reports First Quarter 2018 Financial Results 42

Mar 20, 2018: NovaBay Pharmaceuticals Announces 2017 Fourth Quarter And Full Year Financial Results 43

Jan 08, 2018: NovaBay Pharmaceuticals Announces Preliminary Sales for 2017 Fourth Quarter and Full Year 45

Nov 14, 2017: NovaBay Pharmaceuticals Reports Third Quarter 2017 Financial Results 46

Aug 10, 2017: NovaBay Pharmaceuticals Reports Second Quarter 2017 Financial Results 48

May 11, 2017: NovaBay Pharmaceuticals Reports First Quarter 2017 Financial Results 50

Mar 23, 2017: NovaBay Pharmaceuticals Reports 2016 Full Year and Fourth Quarter Financial Results and Provides 2017 Financial Guidance 52

Jan 09, 2017: Novabay Pharmaceuticals Announces Preliminary Sales For The Fourth Quarter Of 2016 54

Corporate Communications 55

Dec 21, 2017: NovaBay Pharmaceuticals Regains Compliance with NYSE American Continued Listing Standards 55

Jul 10, 2017: NovaBay Pharmaceuticals Announces CFO Transition 56

Appendix 57

Methodology 57

About GlobalData 57

Contact Us 57

Disclaimer 57


List Of Figure

List of Figures

NovaBay Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

NovaBay Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

NovaBay Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

NovaBay Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

NovaBay Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

NovaBay Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

NovaBay Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

NovaBay Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

NovaBay Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 10


List Of Table

List of Tables

NovaBay Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2

NovaBay Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

NovaBay Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

NovaBay Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

NovaBay Pharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 9

NovaBay Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 10

NovaBay Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

ALPHAEON Enters into Agreement with NovaBay Pharma 13

NovaBay Pharma Enters into Distribution Agreement with Cardinal Health for Avenova 14

NovaBay Pharma Enters into Distribution Agreement with Biopharm for NeutroPhase 15

NovaBay Pharma and Principle Business Enterprises to Sign Distribution Agreement 16

NovaBay Pharma and Integrated Healing Technologies to Sign Distribution Agreement 17

NovaBay Pharma Enters Into Licensing Agreement With China Pioneer Pharma For CelleRx And i-Lid Cleanser 18

Shin Poong Enters Into Licensing Agreement With NovaBay For NeutroPhase 19

NovaBay Pharma Raises USD5.9 Million in Private Placement of Shares 20

NovaBay Pharma Files Registration Statement for Public Offering of Shares 22

NovaBay Pharma to Raise USD10.3 Million in Private Placement of Shares 23

NovaBay Pharma Raises USD0.9 Million in Private Placement of Shares upon Exercise of Warrants 24

NovaBay Pharma Raises USD7 Million in Private Placement of Shares upon Exercise of Warrants 25

NovaBay Pharma Raises USD6.9 Million in Private Placement of Shares upon Exercise of Warrants 26

NovaBay Pharma Raises USD4 Million in Second and Final Tranche of Private Placement of Units 27

NovaBay Pharma Raises USD7.8 Million in First Tranche of Private Placement of Units 28

NovaBay Pharma Raises USD2.8 Million in Private Placement of Shares 29

NovaBay Pharma Raises USD2.5 Million in Public Offering of Shares 30

NovaBay Pharma Raises USD6.9 Million in Private Placement of Shares and Warrants 32

NovaBay Pharma Raises USD4.7 Million in Private Placement of Units 33

NovaBay Pharma Raises USD6.7 Million in Public Offering of Units 34

NovaBay Pharma Completes Public Offering Of Shares For USD 7 Million 35

Ch-Gemstone Acquires 37.14% Stake in NovaBay Pharma for USD27.1 Million 36

NovaBay Pharmaceuticals Inc, Key Competitors 37

NovaBay Pharmaceuticals Inc, Key Employees 38

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

NovaBay Pharmaceuticals Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Summary

NovaBay Pharmaceuticals Inc (NovaBay), formerly NovaCal Pharmaceuticals Inc is a biopharmaceutical company that discovers and develops eyecare products. The company's products include skin and wound cleanser, daily lid and lash hygiene spray solutions, and cosetic procedures. Its daily lid and lash hygiene spray solution helps in removal of foreign materials such as microorganisms and debris on and around the lid and eyelid margins. NovaBay develops aganocide compound through research and development based on the human body's natural immune system and molecules involved in combating infections. The company's products find application in therapeutic areas such as ophthalmology, wound care, dermatology, and neutrophase. It partners with pharmaceutical and biotech companies. NovaBay is headquartered in Emeryville, California, the US.

NovaBay Pharmaceuticals Inc (NBY)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

NovaBay Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

NovaBay Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

NovaBay Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

NovaBay Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

NovaBay Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 10

NovaBay Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

NovaBay Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 13

Partnerships 13

ALPHAEON Enters into Agreement with NovaBay Pharma 13

NovaBay Pharma Enters into Distribution Agreement with Cardinal Health for Avenova 14

NovaBay Pharma Enters into Distribution Agreement with Biopharm for NeutroPhase 15

NovaBay Pharma and Principle Business Enterprises to Sign Distribution Agreement 16

NovaBay Pharma and Integrated Healing Technologies to Sign Distribution Agreement 17

Licensing Agreements 18

NovaBay Pharma Enters Into Licensing Agreement With China Pioneer Pharma For CelleRx And i-Lid Cleanser 18

Shin Poong Enters Into Licensing Agreement With NovaBay For NeutroPhase 19

Equity Offering 20

NovaBay Pharma Raises USD5.9 Million in Private Placement of Shares 20

NovaBay Pharma Files Registration Statement for Public Offering of Shares 22

NovaBay Pharma to Raise USD10.3 Million in Private Placement of Shares 23

NovaBay Pharma Raises USD0.9 Million in Private Placement of Shares upon Exercise of Warrants 24

NovaBay Pharma Raises USD7 Million in Private Placement of Shares upon Exercise of Warrants 25

NovaBay Pharma Raises USD6.9 Million in Private Placement of Shares upon Exercise of Warrants 26

NovaBay Pharma Raises USD4 Million in Second and Final Tranche of Private Placement of Units 27

NovaBay Pharma Raises USD7.8 Million in First Tranche of Private Placement of Units 28

NovaBay Pharma Raises USD2.8 Million in Private Placement of Shares 29

NovaBay Pharma Raises USD2.5 Million in Public Offering of Shares 30

NovaBay Pharma Raises USD6.9 Million in Private Placement of Shares and Warrants 32

NovaBay Pharma Raises USD4.7 Million in Private Placement of Units 33

NovaBay Pharma Raises USD6.7 Million in Public Offering of Units 34

NovaBay Pharma Completes Public Offering Of Shares For USD 7 Million 35

Acquisition 36

Ch-Gemstone Acquires 37.14% Stake in NovaBay Pharma for USD27.1 Million 36

NovaBay Pharmaceuticals Inc-Key Competitors 37

NovaBay Pharmaceuticals Inc-Key Employees 38

NovaBay Pharmaceuticals Inc-Locations And Subsidiaries 39

Head Office 39

Recent Developments 40

Financial Announcements 40

Aug 07, 2018: Novabay Pharmaceuticals announces second quarter 2018 financial results 40

May 10, 2018: NovaBay Pharmaceuticals Reports First Quarter 2018 Financial Results 42

Mar 20, 2018: NovaBay Pharmaceuticals Announces 2017 Fourth Quarter And Full Year Financial Results 43

Jan 08, 2018: NovaBay Pharmaceuticals Announces Preliminary Sales for 2017 Fourth Quarter and Full Year 45

Nov 14, 2017: NovaBay Pharmaceuticals Reports Third Quarter 2017 Financial Results 46

Aug 10, 2017: NovaBay Pharmaceuticals Reports Second Quarter 2017 Financial Results 48

May 11, 2017: NovaBay Pharmaceuticals Reports First Quarter 2017 Financial Results 50

Mar 23, 2017: NovaBay Pharmaceuticals Reports 2016 Full Year and Fourth Quarter Financial Results and Provides 2017 Financial Guidance 52

Jan 09, 2017: Novabay Pharmaceuticals Announces Preliminary Sales For The Fourth Quarter Of 2016 54

Corporate Communications 55

Dec 21, 2017: NovaBay Pharmaceuticals Regains Compliance with NYSE American Continued Listing Standards 55

Jul 10, 2017: NovaBay Pharmaceuticals Announces CFO Transition 56

Appendix 57

Methodology 57

About GlobalData 57

Contact Us 57

Disclaimer 57


List Of Figure

List of Figures

NovaBay Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

NovaBay Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

NovaBay Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

NovaBay Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

NovaBay Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

NovaBay Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

NovaBay Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

NovaBay Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

NovaBay Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 10


List Of Table

List of Tables

NovaBay Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2

NovaBay Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

NovaBay Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

NovaBay Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

NovaBay Pharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 9

NovaBay Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 10

NovaBay Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

ALPHAEON Enters into Agreement with NovaBay Pharma 13

NovaBay Pharma Enters into Distribution Agreement with Cardinal Health for Avenova 14

NovaBay Pharma Enters into Distribution Agreement with Biopharm for NeutroPhase 15

NovaBay Pharma and Principle Business Enterprises to Sign Distribution Agreement 16

NovaBay Pharma and Integrated Healing Technologies to Sign Distribution Agreement 17

NovaBay Pharma Enters Into Licensing Agreement With China Pioneer Pharma For CelleRx And i-Lid Cleanser 18

Shin Poong Enters Into Licensing Agreement With NovaBay For NeutroPhase 19

NovaBay Pharma Raises USD5.9 Million in Private Placement of Shares 20

NovaBay Pharma Files Registration Statement for Public Offering of Shares 22

NovaBay Pharma to Raise USD10.3 Million in Private Placement of Shares 23

NovaBay Pharma Raises USD0.9 Million in Private Placement of Shares upon Exercise of Warrants 24

NovaBay Pharma Raises USD7 Million in Private Placement of Shares upon Exercise of Warrants 25

NovaBay Pharma Raises USD6.9 Million in Private Placement of Shares upon Exercise of Warrants 26

NovaBay Pharma Raises USD4 Million in Second and Final Tranche of Private Placement of Units 27

NovaBay Pharma Raises USD7.8 Million in First Tranche of Private Placement of Units 28

NovaBay Pharma Raises USD2.8 Million in Private Placement of Shares 29

NovaBay Pharma Raises USD2.5 Million in Public Offering of Shares 30

NovaBay Pharma Raises USD6.9 Million in Private Placement of Shares and Warrants 32

NovaBay Pharma Raises USD4.7 Million in Private Placement of Units 33

NovaBay Pharma Raises USD6.7 Million in Public Offering of Units 34

NovaBay Pharma Completes Public Offering Of Shares For USD 7 Million 35

Ch-Gemstone Acquires 37.14% Stake in NovaBay Pharma for USD27.1 Million 36

NovaBay Pharmaceuticals Inc, Key Competitors 37

NovaBay Pharmaceuticals Inc, Key Employees 38

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

NovaBay Pharmaceuticals Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

chat_bubbleLet's Chat